COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 370.7 | 2 | 0094-0517 | 202.43 | 517.49 | 317 | 67.36 | 0.878 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2299.5 | 2 | 0095-0523 | 87.21 | 522.84 | 469 | 81.50 | 0.887 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 532.8 | 2 | 0096-0521 | 771.81 | 521.83 | 313 | 68.77 | 0.832 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 435.6 | 2 | 0097-0538 | 125.28 | 538.27 | 288 | 62.53 | 0.926 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 453.2 | 2 | 0098-0537 | 646.98 | 536.44 | 248 | 62.18 | 0.806 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 350.2 | 2 | 0099-0545 | 186.16 | 545.47 | 349 | 70.43 | 0.884 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 336.7 | 2 | 0100-0562 | 460.22 | 561.46 | 366 | 74.43 | 0.830 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 419.6 | 2 | 0101-0559 | 846.47 | 559.65 | 280 | 61.60 | 0.927 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 377.3 | 2 | 0102-0581 | 830.65 | 580.36 | 296 | 64.77 | 0.887 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 426.4 | 2 | 0103-0584 | 729.87 | 584.27 | 309 | 67.94 | 0.841 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 398.7 | 2 | 0104-0583 | 136.86 | 584.11 | 355 | 70.77 | 0.891 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1082.2 | 2 | 0105-0593 | 204.94 | 592.65 | 333 | 67.84 | 0.909 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 380.1 | 2 | 0106-0599 | 657.62 | 599.28 | 352 | 72.77 | 0.835 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 918.8 | 2 | 0107-0612 | 401.82 | 612.35 | 416 | 77.26 | 0.876 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 342.0 | 2 | 0108-0613 | 282.94 | 613.38 | 336 | 69.60 | 0.872 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 334.8 | 2 | 0109-0617 | 794.31 | 617.48 | 364 | 74.43 | 0.826 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 391.9 | 2 | 0110-0627 | 564.76 | 627.74 | 304 | 68.33 | 0.818 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 423.2 | 2 | 0111-0628 | 503.68 | 628.54 | 265 | 60.43 | 0.912 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 348.3 | 2 | 0112-0640 | 468.48 | 639.76 | 358 | 74.77 | 0.805 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 552.3 | 2 | 0113-0637 | 533.36 | 637.27 | 300 | 64.43 | 0.908 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 984.0 | 2 | 0114-0638 | 142.53 | 638.49 | 284 | 62.28 | 0.920 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 419.8 | 2 | 0115-0642 | 923.09 | 642.55 | 259 | 61.36 | 0.865 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2819.4 | 2 | 0116-0649 | 490.89 | 649.79 | 358 | 75.60 | 0.787 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 276.8 | 2 | 0117-0649 | 649.70 | 649.95 | 364 | 70.43 | 0.922 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 609.0 | 2 | 0118-0651 | 340.95 | 651.50 | 256 | 60.53 | 0.878 |